Home > Blog Tag

Blog Posts by Tag: COVID-19

COVID-19's Impact on Lab Industry Testing Volumes and Dynamics — January 2021 Update

During a recent update on COVID-19's impact on lab testing volumes and dynamics, XIFIN Executive Chairman & CEO Lâle White said XIFIN is continuing to see a week over week increase in the overall volume of PCR testing following the winter holidays. Testing volume for December overall saw a slight downshift, mostly due to holiday activity. "The base volume is really back for most of the...

Read


Top 5 Blog Posts of 2020

Through one of the most challenging years for the healthcare industry, XIFIN contributed thought-provoking articles to help traverse these difficult times. Here are 2020's most popular blog posts.1. How Upcoming Changes to United Health's Laboratory Test Registry May Impact Your LabWhen the COVID-19 pandemic was declared, United Healthcare (UHC) delayed implementing the Laboratory Test Registry...

Read


Labs’ Critical Role in the Patient Care Journey and the Many Challenges to Keep up with COVID Testing Volumes

Enjoy the following content from our partner, FrontRunnerHC. For many years, labs — both independent labs and within hospitals — have worked behind the scenes, quietly playing a critical role in the patient care journey. In fact, the lab is often one of the first crucial steps in that journey, providing information to help keep us, or potentially get us, healthy.In many ways, the COVID-19...

Read


Digital Pathology Trends and the Impact of COVID-19 on Speed of Adoption

Digital pathology was introduced decades ago as a way for sharing digital images across laboratories, enabling pathologists to work together on cases and enhance the accuracy of diagnostic techniques. Before the COVID-19 pandemic, U.S. adoption of digital pathology lagged behind most other developed countries.The COVID-19 pandemic accelerated the adoption of digital pathology in this country for...

Read


The CDC Offers a Multi-Virus Testing Option with the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

With flu season typically starting in October and peaking between December and February, the Centers for Disease Control and Prevention (CDC) have developed two tests that identify the COVID-19 virus (SARS-CoV-2). The latest of these two tests, called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, tests for influenza A and B viruses as well as SARS-CoV-2.Along with the new test, the...

Read


3 Ways COVID-19 Will Impact Q4 Testing

As COVID continues to challenge the laboratory industry, XIFIN executives expect a 15% increase in COVID-19 volumes in the fall and regional labs to pick up overflow from larger, national players.This news was announced at a recent conference called “COVID-19’s Impact on Lab Industry Testing Volumes and Dynamics – September Update,” where XIFIN CEO Lâle White, XIFIN Executive Vice President...

Read


Is the FDA on a Dangerous Path? Overstepping LDT Authority Hampered COVID Response and Has Long Term Consequences for US Healthcare

As I recently discussed during my session at this year’s Executive War College, one important aspect of the COVID pandemic and laboratory testing during this time is how it exemplified the detrimental consequences of FDA overreach — which contributed in large part to testing delays and a hamstrung response in the outbreak’s early days — and how that overstepping poses risk going forward. On July...

Read


Insurers Not Required to Reimburse COVID-19 Tests for Returning Workers

According to newly released guidelines from the Trump Administration, insurers will not have to cover COVID-19 screening tests mandated by employers for returning employees.Until these new guidelines, The Families First Coronavirus Response Act required insurers to cover COVID-19 testing without patient cost-sharing. The latest announcement said the law applies only to tests considered medically...

Read